FP&A Manager

Vera Therapeutics is a commercial-stage biotechnology company focused on the pursuit of truth in science to transform medicine in autoimmune disease, starting with the kidney. Vera Therapeutics’ flagship commercial product is TRUTAKNATM (atacicept-vymj), a B-cell activating factor (BAFF) and A proliferation-inducing ligand ( APRIL) inhibitor. Vera Therapeutics is evaluating multiple diseases where the reduction of autoantibodies through inhibition of BAFF and APRIL may prove clinically meaningful.

Vera Therapeutics was founded in 2016 and is based in Brisbane, California. com . At Vera, our values are the cornerstone of our culture and guide how we work together every day.

We lead with empathy, act with an owner’s mindset, demand clarity, work without fences, and execute with urgency because patients are counting on us. From how we hire and develop our people to how we advance rigorous science, we are building a team committed to transforming medicine in autoimmune diseases, starting with the kidney. Position Summary The FP A Manager will report to Sr.

Director, FP A, and will be responsible for the successful execution of FP A activities including budgeting, BVA, forecasting, reporting and decision support. This role will work with cross-functional Vera Therapeutics team members including R D, finance and accounting, and other business functions. This role requires a strategic thinker with strong analytical skills, a deep understanding of clinical finance, and the ability to translate complex financial and operational analysis into clear, audience-appropriate messaging.

This is a highly visible role that provides financial insights critical to executive decision-making.

Responsibilities

Serve as the dedicated finance business partner to functional leaders leading budgeting, forecasting, long-range planning, and variance analysis. Communicate financial analysis in a clear, operationally grounded way, discerning the message based on audience. Own and maintain clinical trial financial models incorporating protocol design, CRO budgets, investigator grants, enrollment assumptions, site activation schedules, and visit-based cost drivers to support forecasting and scenario planning.

, enrollment rates, site activations, protocol amendments, vendor activity) to identify drivers of variances. Prepare study-level financial summaries that reflect the operational dynamics, and present the message in a clear thoughtful manner. Review and validate clinical trial forecasts generated within Auxilius, ensuring operational assumptions are accurate and financial outputs appropriately reflect study execution.

Build multi-year trackers to track preclinical/discovery spend, including milestone-based investment tracking. Review purchase requisitions and purchase orders to ensure financial accuracy and support standardized procure-to-pay processes. Partner with Accounting on month end close, month-end accruals and perform procedures to ensure account and department coding is consistent.

Support automation initiatives that improve forecasting accuracy, reporting efficiency, and data quality across FP A processes. Develop trusted relationships with functional leaders, to provide financial recommendations that support operational decision-making.

Qualifications

Bachelor’s degree in finance, accounting, economics, or a field related to drug development. 5-7+ years of experience, biopharma or life science industries. , CRO budget grids, site activation and enrollment-driven cost projections, investigator grant models) within a biopharma or life sciences setting.

Highly collaborative with exceptional consulting, project management, communication, and problem-solving skills.